CNS Pharmaceuticals, Inc. (CNSP)
NASDAQ: CNSP · Real-Time Price · USD
3.240
+0.060 (1.89%)
Feb 19, 2026, 12:25 PM EST - Market open
CNS Pharmaceuticals Employees
As of December 31, 2024, CNS Pharmaceuticals had 5 total employees, including 3 full-time and 2 part-time employees. The number of employees did not change compared to the previous year.
Employees
5
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,614,226
Market Cap
2.01M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 5 | 0 | - | 4 | 1 |
| Dec 31, 2023 | 5 | 0 | - | 3 | 2 |
| Dec 31, 2022 | 5 | 0 | - | 3 | 2 |
| Dec 31, 2021 | 5 | 0 | - | 3 | 2 |
| Dec 31, 2020 | 5 | 0 | - | 3 | 2 |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| HCW Biologics | 36 |
| Scinai Immunotherapeutics | 31 |
| Lyra Therapeutics | 30 |
| Abpro Holdings | 15 |
| Cardio Diagnostics Holdings | 15 |
| Azitra | 12 |
| BioRestorative Therapies | 11 |
| CDT Equity | 6 |
CNSP News
- 2 days ago - CNS Pharmaceuticals Appoints Multiple Key Executives to Drive Company's Recently Initiated Strategic Transformation - Accesswire
- 23 days ago - CNS Pharmaceuticals Issues Letter to Shareholders - Accesswire
- 2 months ago - CNS Pharmaceuticals Announces CEO Transition - Accesswire
- 3 months ago - CNS Pharmaceuticals, Inc. (CNSP) Shareholder/Analyst Call Prepared Remarks Transcript - Seeking Alpha
- 3 months ago - CNS Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Corporate Update - Accesswire
- 3 months ago - CNS Pharmaceuticals Announces Acceptance of Three Abstracts for Poster Presentation at the Society of NueroOncology (SNO) 30th Annual Meeting - Accesswire
- 6 months ago - CNS Pharmaceuticals to Present at the H.C. Wainwright 27th Annual Global Investment Conference - Accesswire
- 6 months ago - CNS Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Corporate Update - Accesswire